Prostate Cancer : Episode 11

Video

Episode 11 - Personalized Medicine in CRPC

During this segment, the panelists explore the use of personalized medicine in castration-resistant prostate cancer.

Jeffrey D. Dunn, PharmD, MBA, and Raoul S. Concepcion, MD, explain that clinicians hope to have better data available in the future to provide definitive answers about treatment options for specific patient populations.

Dr Concepcion explains the variables that are being reviewed to help clinicians make wiser treatment decisions for their patients.

However, E. David Crawford, MD, reminds the panelists why achieving this goal will not be easy.


Related Videos
dr jennifer vidrine
dr brian koffman
mily Touloukian, DO, medical oncologist, practice president, and managing partner at Coastal Cancer Center
Amy Shapiro, MD, medical director, Indiana Hemophilia and Thrombosis Center
dr thomas hall
Neal Shore, MD, FACS, an expert on bladder cancer
Neal Shore, MD, FACS, an expert on bladder cancer
RAvin Ratan, MD, MEd, MD Anderson
Amy Shapiro, MD
Related Content
CH LogoCenter for Biosimilars Logo